• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Century Therapeutics, Inc. - Common Stock (NQ:IPSC)

0.5319 -0.0157 (-2.87%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 711,875
Open 0.5350
Bid (Size) 0.5270 (4)
Ask (Size) 0.5400 (19)
Prev. Close 0.5476
Today's Range 0.5200 - 0.5690
52wk Range 0.3418 - 2.160
Shares Outstanding 85,029,042
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Monday's after hours session: top gainers and losers
July 07, 2025
As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill
Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress
May 28, 2025
From Century Therapeutics, Inc.
Via GlobeNewswire

Performance

YTD
-48.9%
-48.9%
1 Month
-4.2%
-4.2%
3 Month
-5.2%
-5.2%
6 Month
-31.8%
-31.8%
1 Year
-72.9%
-72.9%

More News

Read More
Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
May 15, 2025
From Century Therapeutics, Inc.
Via GlobeNewswire
4 Analysts Have This To Say About Century Therapeutics
January 22, 2025
Via Benzinga
5 Analysts Assess Century Therapeutics: What You Need To Know
June 04, 2024
Via Benzinga
Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting
April 28, 2025
From Century Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 16, 2025
Via Benzinga
Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025
April 15, 2025
From Century Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
March 28, 2025
Via Benzinga
Carnival To Rally Around 48%? Here Are 10 Top Analyst Forecasts For Monday
March 24, 2025
Via Benzinga
Demystifying Century Therapeutics: Insights From 4 Analyst Reviews
March 21, 2025
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 19, 2025
Via Benzinga
Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
March 19, 2025
From Century Therapeutics, Inc.
Via GlobeNewswire
Century Therapeutics Announces Investigator-Initiated Phase 1/2 Trial of its iPSC-derived iNK Cell Therapy CNTY-101 in B-cell Mediated Autoimmune Diseases Sponsored by Internationally Renowned Key Opinion Leaders
January 21, 2025
From Century Therapeutics, Inc.
Via GlobeNewswire
Century Therapeutics Stages Highest Single Day Move In 11 Months As Casdin Capital Bumps Its Stake To 5.4%
November 28, 2024
Via Benzinga
Century Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference
November 26, 2024
From Century Therapeutics, Inc.
Via GlobeNewswire
Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 05, 2024
From Century Therapeutics, Inc.
Via GlobeNewswire
Century Therapeutics Announces Upcoming Poster Presentations at the 2024 American Society of Hematology (ASH) Annual Meeting
November 05, 2024
From Century Therapeutics, Inc.
Via GlobeNewswire
Century Therapeutics to Present at Guggenheim’s Inaugural Healthcare Innovation Conference
November 04, 2024
From Century Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
October 03, 2024
Via Benzinga
Century Therapeutics Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Scientific Officer
September 26, 2024
From Century Therapeutics, Inc.
Via GlobeNewswire
Robinhood To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Thursday
August 15, 2024
Via Benzinga
IPSC Stock Earnings: Century Therapeutics Beats EPS for Q2 2024
August 08, 2024
Via InvestorPlace
Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
August 08, 2024
From Century Therapeutics, Inc.
Via GlobeNewswire
Century Therapeutics Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting
June 03, 2024
From Century Therapeutics, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Century Therapeutics, Inc. - Common Stock publicly traded?
Yes, Century Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Century Therapeutics, Inc. - Common Stock trade on?
Century Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Century Therapeutics, Inc. - Common Stock?
The ticker symbol for Century Therapeutics, Inc. - Common Stock is IPSC on the Nasdaq Stock Market
What is the current price of Century Therapeutics, Inc. - Common Stock?
The current price of Century Therapeutics, Inc. - Common Stock is 0.5319
When was Century Therapeutics, Inc. - Common Stock last traded?
The last trade of Century Therapeutics, Inc. - Common Stock was at 08/01/25 04:00 PM ET
What is the market capitalization of Century Therapeutics, Inc. - Common Stock?
The market capitalization of Century Therapeutics, Inc. - Common Stock is 45.23M
How many shares of Century Therapeutics, Inc. - Common Stock are outstanding?
Century Therapeutics, Inc. - Common Stock has 45M shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap